Data‑driven equity research.
Stock Analyst Research delivers institutional‑grade analysis of Indian stock markets. Our recommendations blend fundamental strength with technical timing.
MARKET OUTLOOK · Q2 2026
Nifty 50: rangebound with bullish tilt
Support at 24,200; resistance 25,100. Banking and IT likely to lead. FII buying improved in last fortnight.
🔼 4.2% expected upsideSECTOR WATCH
Pharma & Defence in focus
Government Capex push and USFDA approvals buoy Pharma. Defence order book at record high.
⚡ momentum strongECONOMIC INDICATOR
CPI inflation cools to 4.7%
Lower crude and food prices boost sentiment. RBI likely to hold rates, but commentary dovish.
📉 inflation under controlTailored investment solutions
Strategies designed for different horizons — all backed by rigorous research.
Multibagger Stocks
target 100%+ · under 4 months
High‑conviction ideas from small & midcap space. Fundamental bottom‑up research with growth catalysts.
Weekly Jackpot
10–15% weekly · short term
Momentum picks with high probability setup. Strict stop loss and risk‑reward of minimum 1:3.
Sure Shot Intraday
daily calls · high accuracy
Level‑based trading calls with live entry, target & stoploss. Derived from option chain and OI analysis.
⚡ Indian equity market overview
📈 Nifty Midcap 150 +14% YTD
💼 FII net buyers ₹26,000 Cr in May
🏭 Q4 earnings beat in 62% of Nifty cos
12.3%
Nifty 1Y return
19.8%
Midcap 1Y return
26
stocks with 'buy' rec.
Our research model combines quarterly earnings revision, FII/DII activity, and technical breakout confirmation.
⏤ research discipline · transparency · consistent returns ⏤